Multiple Myeloma |
From the Department of Immunology, St. Helier Hospital, Carshalton, Surrey, UK (MJA); Section of Haemato-Oncology, The Royal Marsden NHS Foundation Trust, UK (FED, DdC, GJM)
Correspondence: Michael J. Ayliffe, Department of Immunology, St Helier Hospital Wrythe Lane, Carshalton, Surrey, SM3 8NR, UK. E-mail: michael.ayliffe{at}onetel.net
Increases in free light chain (FLC) production are associated with disease progression in multiple myeloma (MM). Using a double immunofluorescence staining method to produce a differential count of plasma cells in bone marrow, single populations were demonstrated, containing intact monoclonal immunoglobulins (M-Igs) in 74% and FLCs only in 8% of cases. However, 18% contained a mixture of both cell populations. Progression from cells making intact M-Ig to cells restricted to FLC only production occurred in individual cases during the course of their disease. The presence of FLC only cells was associated with shortened survival.
Key words: multiple myeloma, bone marrow, plasma cells, free light chains, monoclonal immunoglobulins.
This article has been cited by other articles:
![]() |
G. P. Mead and M. T. Drayson Sensitivity of serum free light chain measurement of residual disease in multiple myeloma patients Blood, August 20, 2009; 114(8): 1717 - 1717. [Full Text] [PDF] |
||||